Corporate information

12 Months Ended

Dec. 31, 2025

Corporate Information [Abstract]

Corporate Information

Corporate information

Telix Pharmaceuticals Limited ("Telix" or "the Company") is a for-profit company incorporated and domiciled in Australia.

It is limited by shares that are publicly traded on the Australian Securities Exchange (ASX: TLX) and on the Nasdaq Global

Select Market (NASDAQ: TLX). These consolidated financial statements comprise the results of Telix and its subsidiaries

(together referred to as "the Group"). The consolidated financial statements were authorized for issue in accordance with

a resolution of the Directors on February 20, 2026.